Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
- - - 0.78x1.71x-1.21x-1.01x 9.81M
-.--%-.--%-32.87x-119.41x10.14x-72.9x-37.34x 12.82B
1.56%1.64%16.54x1.83x1.92x7.7x11.4x 9.99B
2.74%3.19%21.14x3.88x7.31x16.5x17.9x 5.71B
-.--%-.--%135.67x6.27x3.99x25.01x66.77x 4.51B
2.03%2.17%20.06x1.93x3.35x10.38x14.35x 4.17B
3.65%4.04%17.57x2.13x - - - 2.94B
-.--%-.--%-24.28x3.26x3.45x-29.18x-17.55x 2.6B
0.98%0.67%29.37x1.77x4.29x13.47x21.68x 1.59B
2.73%2.31%38.9x1.56x - - - 1.61B
1.16%1.7%21.05x3.46x5.07x12.8x14.5x 1.18B
Average 1.48% 1.57% 24.31x -8.41x 4.58x -1.94x 10.08x 4.28B
Weighted average by Cap. 1.22% 1.32% 14.48x -30.35x 5.75x -15.20x 2.44x
Diagnostic & Testing Substances